BioCentury
ARTICLE | Finance

Vivo doubles up

How Vivo Capital plans to invest its largest fund yet in China, U.S.

April 6, 2015 7:00 AM UTC

Vivo Capital believes it can put a larger amount of capital to work in the U.S. and China. So the firm closed its eighth fund late last month with $750 million -- its largest to date and double its $375 million seventh fund.

Vivo invests primarily in U.S. therapeutics and medical device companies with products in the clinic or on the market, and in revenue-generating healthcare companies in greater China. ...